Outcome measures
abnormal fatigue, fatigue, ’, pain, muscle pain, peripheral muscle fatigue, muscle fatigue
BLOOD, SECONDARY
The outcomes were measured baseline, immediately after modeling, 24 h, 48 h, and 72 h. Blood outcomes will not be tested after 48 h of modeling. The outcome measures will be as follows.The primary outcome was muscle pain intensity as measured by the Visual Analogue Scale (VAS). Each VAS will consist of a 100 mm horizontal line with the text ‘no pain’ at the 0 mm mark and ‘worst pain imaginable’ at the 100 mm mark. Participants marked pain levels on the lines according to how they felt.The secondary outcomes were: (1) The biomarkers of peripheral muscle fatigue were used to deeply understand the fatigue mechanism during exercise to detect abnormal fatigue or defective metabolic pathways. Inflammatory factor Interleukin 6 (IL-6) is one of the most commonly used biochemical outcomes to judge muscle fatigue [